Atossa Therapeutics (ATOS) Interest & Investment Income (2011 - 2026)
Atossa Therapeutics' Interest & Investment Income was $227,000 in Q2 2026, down 64.8% from $645,000 a year earlier and down 26.5% from the prior quarter.
Powered by 
Analysis
Atossa Therapeutics (ATOS) Interest & Investment Income (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Atossa Therapeutics' Interest & Investment Income was $1.55 million through Jun 30, 2026, down 51.7% year-over-year; for FY2025, it came in at $2.38 million, down 41.3% from FY2024.
- Interest & Investment Income shows a four-year compound annual growth rate of 346.1% (FY2021 to FY2025).
- In earlier years, Interest & Investment Income was $4.05 million in FY2024 (-6.7%), $4.34 million in FY2023 (+395.2%), $877,000 in FY2022 and $6,000 in FY2021.
- The Q2 2026 figure marks the lowest quarterly Interest & Investment Income since Q3 2022.
- Compared with a year earlier, Interest & Investment Income has declined for eight straight quarters, with an average decline of 42.8% over the last eight quarters.
- The best year-over-year quarter for Interest & Investment Income over five years was Q3 2023 (growth of 556.7%); the worst was Q2 2026 (a decline of 64.8%).
- Per Business Quant data, ATOS's Interest & Investment Income in the three quarters before Q2 2026 was $309,000 (Q1 2026), $442,000 (Q4 2025) and $570,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Atossa Therapeutics | 23.35 Mn | 23.35 Mn | - | 227,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 227,000.00 |
| Mar 31, 2026 | 309,000.00 |
| Dec 31, 2025 | 442,000.00 |
| Sep 30, 2025 | 570,000.00 |
| Jun 30, 2025 | 645,000.00 |
| Mar 31, 2025 | 720,000.00 |
| Dec 31, 2024 | 837,000.00 |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 1.24 Mn |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 983,000.00 |
| Mar 31, 2023 | 850,000.00 |
| Dec 31, 2022 | 670,000.00 |
| Sep 30, 2022 | 194,000.00 |
| Jun 30, 2022 | 11,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Mar 31, 2015 | 279.00 |
| Dec 31, 2014 | 106.00 |
API Access
Atossa Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();